| 000 | 00980 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516091827.0 | ||
| 264 | 0 | _c20120724 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a0171-2004 | ||
| 024 | 7 |
_a10.1007/978-3-642-23056-1_11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPai, Menaka | |
| 245 | 0 | 0 |
_aNeutralization of heparin activity. _h[electronic resource] |
| 260 |
_bHandbook of experimental pharmacology _c2012 |
||
| 300 |
_a265-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aFactor VIIa _xpharmacology |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Factor 4 _xpharmacology |
| 650 | 0 | 4 |
_aProtamines _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 700 | 1 | _aCrowther, Mark A | |
| 773 | 0 |
_tHandbook of experimental pharmacology _gno. 207 _gp. 265-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-642-23056-1_11 _zAvailable from publisher's website |
| 999 |
_c21762627 _d21762627 |
||